ENCORE: Topline Results of a Phase Three Open-label Extension and Randomized-withdrawal Trial of AXS-12 in Narcolepsy

reboxetine (AXS-12) - Axsome Therap

Richard Bogan1; Michael Thorpy2; Lois Krahn3; Bruce Corser4; Colin Shapiro5; Dan Chen6; Angad Chhabra6; Eileen Leary7; Herriot Tabuteau6

Mar 6, 2026